These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6114627)

  • 21. Neuropharmacology of amino acid inhibitory transmitters.
    Johnston GA
    Annu Rev Pharmacol Toxicol; 1978; 18():269-89. PubMed ID: 25608
    [No Abstract]   [Full Text] [Related]  

  • 22. Is glycine an inhibitory synaptic transmitter in the substantia nigra?
    James TA; Starr MS
    Eur J Pharmacol; 1979 Aug; 57(2-3):115-25. PubMed ID: 39765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of GABA release by dopamine in the substantia nigra.
    Matuszewich L; Yamamoto BK
    Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABA inhibition of 3H-glycine release from slices of rat substantia nigra in vitro.
    Kerwin R; Pycock C
    Eur J Pharmacol; 1980 Jun; 64(2-3):169-72. PubMed ID: 7398760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preemptive analgesia].
    Goto T
    Masui; 1997 Nov; 46 Suppl():S179-80. PubMed ID: 9508574
    [No Abstract]   [Full Text] [Related]  

  • 26. Electrical stimulation of the substantia nigra reticulata: detection of neuronal extracellular GABA in the ventromedial thalamus and its regulatory mechanism using microdialysis in awake rats.
    Timmerman W; Westerink BH
    Synapse; 1997 May; 26(1):62-71. PubMed ID: 9097406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticonvulsant action of GABAergic drugs: cellular and anatomical localization of their site of action in vivo.
    Gale K; Iadarola MJ; Casu M
    Prog Clin Biol Res; 1983; 124():39-62. PubMed ID: 6878396
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings: Topographical study of the distribution of GABA in the human substantia nigra.
    Kanazawa I; Kelly JS
    Br J Pharmacol; 1975 Oct; 55(2):309P. PubMed ID: 1201435
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunocytochemical localization of glycine in the lamprey spinal cord with reference to GABAergic and glutamatergic synapses: a light and electron microscopic study.
    Shupliakov O; Fagerstedt P; Ottersen OP; Storm-Mathiesen J; Grillner S; Brodin L
    Acta Biol Hung; 1996; 47(1-4):393-410. PubMed ID: 9124008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Amino acid neuromediators].
    Curtis DR
    Farmakol Toksikol; 1989; 52(6):4-18. PubMed ID: 2576233
    [No Abstract]   [Full Text] [Related]  

  • 31. GABA and glycine as inhibitory neurotransmitters in the vestibuloocular reflex.
    Spencer RF; Baker R
    Ann N Y Acad Sci; 1992 May; 656():602-11. PubMed ID: 1350893
    [No Abstract]   [Full Text] [Related]  

  • 32. Neurochemical aspects of amino acid transmitters and modulators.
    Oja SS; Kontro P
    Med Biol; 1987; 65(2-3):143-52. PubMed ID: 2888930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo release of 3H-GABA synthesized from 3H-Glutamine in the substantia nigra and the pallido entopeduncular nuclei in the cat.
    Besson MJ; Gauchy C; Kemel ML; Glowinski J
    Adv Biochem Psychopharmacol; 1981; 30():95-103. PubMed ID: 7331939
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of GABA in the substantia nigra.
    James TA; Starr MS
    Nature; 1978 Sep; 275(5677):229-30. PubMed ID: 692697
    [No Abstract]   [Full Text] [Related]  

  • 35. Interactive role for neurosteroids in ethanol enhancement of gamma-aminobutyric acid-gated currents from dissociated substantia nigra reticulata neurons.
    Criswell HE; McCown TJ; Ming Z; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1054-9. PubMed ID: 10565824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological and physiological properties of parvalbumin- and calretinin-containing gamma-aminobutyric acidergic neurons in the substantia nigra.
    Lee CR; Tepper JM
    J Comp Neurol; 2007 Feb; 500(5):958-72. PubMed ID: 17177263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GABA in the striatonigral and striatopallidal systems as moderator and mediator of striatal functions.
    Scheel-Krüger J
    Adv Neurol; 1984; 40():85-90. PubMed ID: 6141713
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of GABA in the basal ganglia and limbic system for behaviour.
    Scheel-Krüger J; Magelund G; Olianas M
    Adv Biochem Psychopharmacol; 1981; 29():23-36. PubMed ID: 7020365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat.
    Rangel-Barajas C; Silva I; García-Ramírez M; Sánchez-Lemus E; Floran L; Aceves J; Erlij D; Florán B
    Neuropharmacology; 2008 Oct; 55(5):704-11. PubMed ID: 18588904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.